Pith. sign in

REVIEW 9 cited by

PanNuke Dataset Extension, Insights and Baselines

Not yet reviewed by Pith; the record is open.

This paper has not been read by Pith yet. Machine review is queued; the pith claim, tier, and objections will appear here once it completes.

SPECIMEN: schema-true, not a live event

T0 review · schema-true

One-sentence machine reading of the paper's core claim.

pith:XXXXXXXX · record.json · timestamp

arxiv 2003.10778 v7 pith:DUIYCMLQ submitted 2020-03-24 eess.IV cs.CVq-bio.QM

classification eess.IVcs.CVq-bio.QM
keywords datasetnucleipannukeclinicalapplicationappliedchallengingcpath
verification ladder T0 review T1 audit T2 compute T3 formal
0 comments
read the original abstract

The emerging area of computational pathology (CPath) is ripe ground for the application of deep learning (DL) methods to healthcare due to the sheer volume of raw pixel data in whole-slide images (WSIs) of cancerous tissue slides. However, it is imperative for the DL algorithms relying on nuclei-level details to be able to cope with data from `the clinical wild', which tends to be quite challenging. We study, and extend recently released PanNuke dataset consisting of ~200,000 nuclei categorized into 5 clinically important classes for the challenging tasks of segmenting and classifying nuclei in WSIs. Previous pan-cancer datasets consisted of only up to 9 different tissues and up to 21,000 unlabeled nuclei and just over 24,000 labeled nuclei with segmentation masks. PanNuke consists of 19 different tissue types that have been semi-automatically annotated and quality controlled by clinical pathologists, leading to a dataset with statistics similar to the clinical wild and with minimal selection bias. We study the performance of segmentation and classification models when applied to the proposed dataset and demonstrate the application of models trained on PanNuke to whole-slide images. We provide comprehensive statistics about the dataset and outline recommendations and research directions to address the limitations of existing DL tools when applied to real-world CPath applications.

Discussion (0). Continue with ORCID to comment.

Forward citations

Cited by 9 Pith papers

Reviewed papers in the Pith corpus that reference this work. Sorted by Pith novelty score. OpenAlex reports about 156 citations worldwide. Full citation record

  1. The Good, the Bad, and the Brittle: Benchmarking Robustness and Generalisation of Histopathology Foundation Models

    cs.CV 2026-07 conditional novelty 6.0 of 10

    Mid-sized pathology foundation models match or beat billion-parameter ones on clinically realistic perturbations and distribution-shift tests, so scaling alone has largely saturated for robustness.

  2. HASSL: Hierarchy-Aware Self-Supervised Learning Framework for Single Cell Microscopy

    cs.CV 2026-07 conditional novelty 6.0 of 10

    A DINO-style SSL method with a segmentation teacher and stability-weighted HDBSCAN contrastive loss improves hierarchical morphology-aware single-cell embeddings over strong baselines.

  3. Atlas H&E-TME: Scalable AI-Based Tissue Profiling at Expert Pathologist-Level Accuracy

    cs.CV 2026-06 unverdicted novelty 6.0 of 10

    Atlas H&E-TME is a new AI system for cell-level tissue profiling on H&E slides that matches pathologist performance when validated against an IHC-informed consensus and a large multi-cancer H&E annotation set.

  4. Evaluating Vision Foundation Models for Pixel and Object Classification in Microscopy

    cs.CV 2026-03 conditional novelty 6.0 of 10

    Vision foundation model features improve pixel and object classification in microscopy over hand-crafted features, and object-guided attentive probing (ObAP) can match or beat supervised baselines with very few labels.

  5. PhenoBench: A Comprehensive Benchmark for Cell Phenotyping

    cs.CV 2025-07 conditional novelty 6.0 of 10

    A new H&E benchmark with 14 fine-grained cell types and biological domain splits shows pathology foundation models scoring around 0.20 to 0.28 macro F1, far below their near-saturated performance on older benchmarks.

  6. MorphGen: Morphology-Guided Representation Learning for Robust Single-Domain Generalization in Histopathological Cancer Classification

    cs.CV 2025-08 conditional novelty 5.0 of 10

    MorphGen uses supervised contrastive learning to align histopathology images with nuclear masks and applies SWA, reporting improved out-of-domain cancer classification accuracy on CAMELYON17, BCSS, and OCELOT.

  7. Scalable and Loosely-Coupled Multimodal Deep Learning for Breast Cancer Subtyping

    cs.CV 2025-09 conditional novelty 4.0 of 10

    A multimodal framework fusing CNV, clinical data, and both image- and graph-based histopathology representations improves PAM50 subtyping accuracy to 78.13% and macro-AUC to 0.9153 on TCGA-BRCA.

  8. Cancer cytoplasm segmentation in hyperspectral cell image with data augmentation

    eess.IV 2025-07 conditional novelty 4.0 of 10

    Pseudo-hyperspectral images made from CMOS photos plus synthetic line noise improve cancer cytoplasm segmentation IoU from 0.7255 to 0.7362 on a 56-image test set.

  9. The Four Color Theorem for Cell Instance Segmentation

    cs.CV 2025-06 conditional novelty 4.0 of 10

    FCIS recasts cell instance segmentation as four-class semantic segmentation by four-coloring cell adjacency graphs, and reports top accuracy on DSB2018, PanNuke, BBBC006v1, and YeaZ.

Pith tools